The WHO 2016 guidelines for classification of gliomas include three categories: IDH‐mutant with 1p/19q codeletion, IDH‐mutant without 1p/19q codeletion, and IDH‐wildtype. The gene discussed is IDH2; the disease is central nervous system cancer.